FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313471567> ?p ?o ?g. }

• W4313471567 endingPage "178" @default.
• W4313471567 startingPage "178" @default.
• W4313471567 abstract "Non-Alcoholic Steatohepatitis (NASH) is the progressive form of Non-Alcoholic Fatty Liver Disease (NAFLD). NASH is distinguished by severe hepatic fibrosis and inflammation. The plant-derived, non-psychotropic compound cannabigerol (CBG) has potential anti-inflammatory effects similar to other cannabinoids. However, the impact of CBG on NASH pathology is still unknown. This study demonstrated the therapeutic potential of CBG in reducing hepatic steatosis, fibrosis, and inflammation. Methods: 8-week-old C57BL/6 male mice were fed with methionine/choline deficient (MCD) diet or control (CTR) diets for five weeks. At the beginning of week 4, mice were divided into three sub-groups and injected with either a vehicle, a low or high dose of CBG for two weeks. Overall health of the mice, Hepatic steatosis, fibrosis, and inflammation were evaluated. Results: Increased liver-to-body weight ratio was observed in mice fed with MCD diet, while a low dose of CBG treatment rescued the liver-to-body weight ratio. Hepatic ballooning and leukocyte infiltration were decreased in MCD mice with a low dose of CBG treatment, whereas the CBG treatment did not change the hepatic steatosis. The high dose CBG administration increased inflammation and fibrosis. Similarly, the expression of cannabinoid receptor (CB)1 and CB2 showed decreased expression with the low CBG dose but not with the high CBG dose intervention in the MCD group and were co-localized with mast cells. Additionally, the decreased mast cells were accompanied by decreased expression of transforming growth factor (TGF)-β1. Conclusions: Collectively, the low dose of CBG alleviated hepatic fibrosis and inflammation in MCD-induced NASH, however, the high dose of CBG treatment showed enhanced liver damage when compared to MCD only group. These results will provide pre-clinical data to guide future intervention studies in humans addressing the potential uses of CBG for inflammatory liver pathologies, as well as open the door for further investigation into systemic inflammatory pathologies." @default.
• W4313471567 created "2023-01-06" @default.
• W4313471567 creator A5032461023 @default.
• W4313471567 creator A5041426350 @default.
• W4313471567 creator A5046031840 @default.
• W4313471567 creator A5047599959 @default.
• W4313471567 creator A5050420985 @default.
• W4313471567 creator A5066766981 @default.
• W4313471567 creator A5085747504 @default.
• W4313471567 creator A5086701222 @default.
• W4313471567 date "2022-12-30" @default.
• W4313471567 modified "2023-09-29" @default.
• W4313471567 title "Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor" @default.
• W4313471567 cites W1575469908 @default.
• W4313471567 cites W1596596338 @default.
• W4313471567 cites W1898835919 @default.
• W4313471567 cites W1978984215 @default.
• W4313471567 cites W1984821297 @default.
• W4313471567 cites W1999924323 @default.
• W4313471567 cites W2002349285 @default.
• W4313471567 cites W2022266817 @default.
• W4313471567 cites W2022790785 @default.
• W4313471567 cites W2046118304 @default.
• W4313471567 cites W2046755222 @default.
• W4313471567 cites W2049562714 @default.
• W4313471567 cites W2066233206 @default.
• W4313471567 cites W2104024176 @default.
• W4313471567 cites W2118147078 @default.
• W4313471567 cites W2133811076 @default.
• W4313471567 cites W2146709170 @default.
• W4313471567 cites W2148878254 @default.
• W4313471567 cites W2161164451 @default.
• W4313471567 cites W2204688218 @default.
• W4313471567 cites W2285428110 @default.
• W4313471567 cites W2520882538 @default.
• W4313471567 cites W2532614692 @default.
• W4313471567 cites W2573090827 @default.
• W4313471567 cites W2609029672 @default.
• W4313471567 cites W2756343284 @default.
• W4313471567 cites W2759997926 @default.
• W4313471567 cites W2767025475 @default.
• W4313471567 cites W2767116475 @default.
• W4313471567 cites W2772777089 @default.
• W4313471567 cites W2806773816 @default.
• W4313471567 cites W2897013069 @default.
• W4313471567 cites W2913552709 @default.
• W4313471567 cites W2943280814 @default.
• W4313471567 cites W2983078103 @default.
• W4313471567 cites W3004704324 @default.
• W4313471567 cites W3005214954 @default.
• W4313471567 cites W3009269411 @default.
• W4313471567 cites W3016761874 @default.
• W4313471567 cites W3022772558 @default.
• W4313471567 cites W3047549841 @default.
• W4313471567 cites W3088654978 @default.
• W4313471567 cites W3109480914 @default.
• W4313471567 cites W3112809837 @default.
• W4313471567 cites W3157208641 @default.
• W4313471567 cites W3173205490 @default.
• W4313471567 cites W3185864072 @default.
• W4313471567 cites W3207193144 @default.
• W4313471567 cites W4245318832 @default.
• W4313471567 cites W4248980229 @default.
• W4313471567 doi "https://doi.org/10.3390/nu15010178" @default.
• W4313471567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36615835" @default.
• W4313471567 hasPublicationYear "2022" @default.
• W4313471567 type Work @default.
• W4313471567 citedByCount "3" @default.
• W4313471567 countsByYear W43134715672023 @default.
• W4313471567 crossrefType "journal-article" @default.
• W4313471567 hasAuthorship W4313471567A5032461023 @default.
• W4313471567 hasAuthorship W4313471567A5041426350 @default.
• W4313471567 hasAuthorship W4313471567A5046031840 @default.
• W4313471567 hasAuthorship W4313471567A5047599959 @default.
• W4313471567 hasAuthorship W4313471567A5050420985 @default.
• W4313471567 hasAuthorship W4313471567A5066766981 @default.
• W4313471567 hasAuthorship W4313471567A5085747504 @default.
• W4313471567 hasAuthorship W4313471567A5086701222 @default.
• W4313471567 hasBestOaLocation W43134715671 @default.
• W4313471567 hasConcept C126322002 @default.
• W4313471567 hasConcept C134018914 @default.
• W4313471567 hasConcept C2776175330 @default.
• W4313471567 hasConcept C2776914184 @default.
• W4313471567 hasConcept C2778772119 @default.
• W4313471567 hasConcept C2779134260 @default.
• W4313471567 hasConcept C2779478299 @default.
• W4313471567 hasConcept C2780559512 @default.
• W4313471567 hasConcept C71924100 @default.
• W4313471567 hasConceptScore W4313471567C126322002 @default.
• W4313471567 hasConceptScore W4313471567C134018914 @default.
• W4313471567 hasConceptScore W4313471567C2776175330 @default.
• W4313471567 hasConceptScore W4313471567C2776914184 @default.
• W4313471567 hasConceptScore W4313471567C2778772119 @default.
• W4313471567 hasConceptScore W4313471567C2779134260 @default.
• W4313471567 hasConceptScore W4313471567C2779478299 @default.
• W4313471567 hasConceptScore W4313471567C2780559512 @default.
• W4313471567 hasConceptScore W4313471567C71924100 @default.
• W4313471567 hasIssue "1" @default.

• next